Given the poor survival observed in IL‐6 deficient mice during influenza and post‐influenza streptococcal pneumonia and the hypothetical use of IL‐6 antagonists during influenza infection, we sought to determine the role of IL‐6 inhibition during post‐influenza MRSA pneumonia. This evidence concerns the gene IL6 and streptococcal pneumonia.